DARUBEKAY HEALTHCARE SOLUTIONS LIMITED

Executive Summary

Darubekay Healthcare Solutions Limited exhibits significant financial deterioration over the past year, with negative net assets and worsening liquidity. The company’s current financial position raises concerns about its ability to meet credit obligations, leading to a decline recommendation for credit facilities. Continuous monitoring of cash flow and capital structure is essential to reassess creditworthiness in the future.

DARUBEKAY HEALTHCARE SOLUTIONS LIMITED - Analysis Report

Company Number: 14120042

Analysis Date: 2025-07-29 18:29 UTC

1. Credit Opinion: DECLINE
   Darubekay Healthcare Solutions Limited demonstrates negative net assets and working capital deterioration in the most recent financial year ending May 2024. The company’s net current assets moved from a positive £607 in 2023 to a negative £4,364 in 2024, and net assets shifted from positive £197 to negative £3,956, indicating worsening liquidity and solvency issues. Such a financial position undermines the company’s ability to meet short-term liabilities and service any credit facility reliably. Given the micro-entity scale and limited financial buffer, extending credit without substantial additional security or guarantees is high risk.

2. Financial Strength: Weak
   The company’s balance sheet shows a sharp decline in current assets from £5,724 in 2023 to £914 in 2024, while current liabilities remain high at £5,278. Fixed assets are minimal and have depreciated slightly. The shareholder's funds have moved into negative territory, reflecting accumulated losses or withdrawals exceeding capital injection. This weakened equity base and poor working capital position point to fragile financial health.

3. Cash Flow Assessment: Constrained
   The substantial drop in current assets, with current liabilities remaining relatively stable, suggests cash flow strain and potential difficulties in managing day-to-day operational expenses and creditor payments. The company’s average number of employees is low (2), indicating a small operating scale, which may limit cash generation capacity. No audit or detailed cash flow statement is available, but the balance sheet trend implies tight liquidity.

4. Monitoring Points:

• Monitor quarterly cash flow statements and debtor collections closely to assess liquidity improvements or further deterioration.
• Watch for any increase in current liabilities or delays in creditor payments that could signal worsening payment discipline.
• Review any capital injections or restructuring efforts by the sole director/shareholder to shore up net assets.
• Track operational performance indicators and any changes in business scale or contracts in the healthcare services segment.